Literature DB >> 1963534

The calcitonin gene peptides: biology and clinical relevance.

M Zaidi1, B S Moonga, P J Bevis, Z A Bascal, L H Breimer.   

Abstract

The calcitonin/CGRP multigene complex encodes a family of peptides: calcitonin, its C-terminal flanking peptide, katacalcin, and a third novel peptide, calcitonin gene-related peptide (CGRP). The 32-amino acid peptide calcitonin inhibits the osteoclast, thereby conserving skeletal mass during periods of potential calcium lack, such as pregnancy, growth, and lactation. This hormonal role is emphasized by observations that lower circulating calcitonin levels are associated with bone loss and that calcitonin replacement prevents further bone loss. Structurally, CGRP resembles calcitonin and has been implicated in neuromodulation and in the physiological regulation of blood flow. Here we review the molecular genetics, structure, and function of the calcitonin-gene peptides as analyzed in the laboratory and focus on more recent clinical studies relating to disorders and therapeutics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963534     DOI: 10.3109/10408369009105900

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  12 in total

Review 1.  Immune regulation of procalcitonin: a biomarker and mediator of infection.

Authors:  G N Matwiyoff; J D Prahl; R J Miller; J J Carmichael; D E Amundson; G Seda; M Daheshia
Journal:  Inflamm Res       Date:  2012-02-22       Impact factor: 4.575

2.  Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma.

Authors:  Alicia Algeciras-Schimnich; Carol M Preissner; J Paul Theobald; Mary S Finseth; Stefan K G Grebe
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

Review 3.  Chemical modification of class II G protein-coupled receptor ligands: frontiers in the development of peptide analogs as neuroendocrine pharmacological therapies.

Authors:  Megan C Chapter; Caitlin M White; Angela DeRidder; Wayne Chadwick; Bronwen Martin; Stuart Maudsley
Journal:  Pharmacol Ther       Date:  2009-08-15       Impact factor: 12.310

Review 4.  Central nervous system binding sites for calcitonin and calcitonin gene-related peptide.

Authors:  P M Sexton
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

5.  Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells.

Authors:  Jing Huang; Lori L Stohl; Xi Zhou; Wanhong Ding; Richard D Granstein
Journal:  Brain Behav Immun       Date:  2011-02-18       Impact factor: 7.217

6.  Involvement of calcitonin gene-related peptide in the modulation of human myometrial contractility during pregnancy.

Authors:  Y L Dong; L Fang; S Kondapaka; P R Gangula; S J Wimalawansa; C Yallampalli
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

7.  Aspects of antibody-catalyzed primary amide hydrolysis.

Authors:  R C Titmas; T S Angeles; R Sugasawara; N Aman; M J Darsley; G Blackburn; M T Martin
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

8.  Calcitonin induces connective tissue growth factor through ERK1/2 signaling in renal tubular cells.

Authors:  Misa Nakamura; Takashi Ozaki; Aiko Ishii; Masayoshi Konishi; Yuji Tsubota; Toru Furui; Hayato Tsuda; Ichiro Mori; Kiichiro Ota; Kennichi Kakudo
Journal:  Exp Mol Med       Date:  2009-05-31       Impact factor: 8.718

9.  Evolution of secretin family GPCR members in the metazoa.

Authors:  João C R Cardoso; Vanda C Pinto; Florbela A Vieira; Melody S Clark; Deborah M Power
Journal:  BMC Evol Biol       Date:  2006-12-13       Impact factor: 3.260

Review 10.  Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).

Authors:  Mihai Lupu; Ana Caruntu; Constantin Caruntu; Laura Maria Lucia Papagheorghe; Mihaela Adriana Ilie; Vlad Voiculescu; Daniel Boda; Carolina Constantin; Cristiana Tanase; Maria Sifaki; Nikolaos Drakoulis; Charalampos Mamoulakis; George Tzanakakis; Monica Neagu; Demetrios A Spandidos; Boris N Izotov; Aristides M Tsatsakis
Journal:  Oncol Rep       Date:  2017-07-13       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.